◄ back to all posts

LLY: Eli Lilly & Co. Stock

Written by | Jul 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 135,493.69
Enterprise Value ($M) 149,446.90
Book Value ($M) 2,480.30
Book Value / Share 2.55
Price / Book 55.55
NCAV ($M) n/a
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) 0.15
Return on Assets (ROA) 0.07
Return on Equity (ROE) 0.28

Liquidity (mrq)
Quick Ratio 0.85
Current Ratio 1.12

Balance Sheet (mrq) ($M)
Current Assets 12,597.50
Assets 38,006.80
Liabilities 35,526.50
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 24,555.70
Operating Income n/a
Net Income 3,232.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted 3.13
Earnings Per Share Basic 3.14

Cash Flow Statement (mra) ($M)
Cash From Operations 5,524.50
Cash from Investing 1,906.00
Cash from Financing 1,906.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-02-14 13G Pnc Financial Services Group, Inc. 5.43
2020-02-12 13G/A Vanguard Group Inc 7.38 -6.26
2020-02-05 13G/A BlackRock Inc. 6.30 -11.71
2020-01-14 13G/A Lilly Endowment Inc 11.90 22.49
2019-02-12 13G/A Wellington Management Group LLP 4.37 -18.26
2018-12-06 13G/A Primecap Management Co/ca/ 4.85 -5.72

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2019-10-25 10-Q LLY / Eli Lilly & Co. 10-Q – Quarterly Report – 10-Q
2019-08-02 10-Q LLY / Eli Lilly & Co. 10-Q – Quarterly Report – 10-Q
2019-05-02 10-Q LLY / Eli Lilly & Co. 10-Q Quarterly Report 10-Q
2019-02-19 10-K LLY / Eli Lilly & Co. 10-K (Annual Report)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-02-14 195,157 2,274,100 8.58
2020-02-13 302,564 3,455,600 8.76
2020-02-12 359,985 3,953,300 9.11
2020-02-11 378,848 2,976,500 12.73
2020-02-10 803,019 4,892,100 16.41

(click for more detail)

Similar Companies
HSP – Hospira JNJ – Johnson & Johnson
LCI – Lannett Co., Inc. MNK – Maillinckrodt plc.
MRK – Merck & Co., Inc.


Financial data and stock pages provided by
Fintel.io




2018/07/06
◄ back to all posts
Holistic